Financials
- Market Capitalization 104.88 M
- Employee 93
- Founded 1999
- CEO N/A
- Website www.cumberlandpharma.com
- Headquarter Tennessee, United States
- FIGI BBG000R93GV7
- Industry 药品制造—专业与仿制药
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-20.95
市销率
1.33
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 3753 | OGI Organigram Global Inc. - Common Shares | 0.93 USD | -3.12% | -1.06% | -11.43% | -34.74% | 125.05 M USD | ||
| 3783 | CRDL Cardiol Therapeutics Inc. - Class A Common Shares | 1.18 USD | -4.07% | -11.28% | -39.80% | +16.83% | 118.30 M USD | ||
| 3956 | ZYBT Zhengye Biotechnology Holding Limited - Class A Ordinary Shares | 1.69 USD | -2.31% | +52.25% | +9.03% | -30.74% | 80.09 M USD | ||
| 3989 | CTOR Citius Oncology, Inc. - Common Stock | 0.81 USD | -3.57% | -8.99% | -11.96% | -30.17% | 75.31 M USD |